CLINICAL_TRIALS
trial_result
· 2012-08-03
Clinical Trial Update: Saxagliptin Triple Oral Therapy [Phase 3]
Summary
Phase 3 trial update focusing on a saxagliptin-containing triple oral therapy for Type 2 diabetes mellitus. The study status is completed and results were poste…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2012-08-03